|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/06 | |
| A61K 31/506 | |||
| A61K 31/505 | |||
| A61P 25/22 | |||
| A61P 25/00 |
| (11) | Patento numeris | 3345902 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18155385.0 |
| Europos patento paraiškos padavimo data | 2014-03-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-10-30 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361786288 P | 2013-03-14 | US |
| (72) |
BOLLU, Venkataiah, US
BREITENBUCHER, James, US
KAPLAN, Alan, US
LEMUS, Robert, US
LINDSTROM, Andrew, US
VICKERS, Troy, US
WILSON, Mark E., US
ZAPF, James, US
WEINHOUSE, Michael I., US
|
| (73) |
Dart Neuroscience (Cayman) Ltd.,
10 Market Street, No. 774 Camana Bay, Grand Cayman, KY1-9006,
KY
|
| (54) | SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS |
| SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS |